Streetbeat News

Products Services

SNOA

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) emphasized the safety benefits of its Microcyn technology products, which are based on stabilized hypochlorous acid (HOCl) for applications such as wound care and dermatological conditions. This comes in response to concerns about benzoyl peroxide, a common dermatology product ingredient.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:37 am

VFS

VinFast Auto Ltd (NASDAQ:VFS) has signed letters of intent with 15 dealers in Thailand to expand its distribution network, planning to open 22 showrooms in the Greater Bangkok Area and other major cities. This move is part of VinFast's strategy to leverage Thailand's high electric vehicle adoption rate and its goal to expand to at least 50 countries by 2024. VFS shares rose 0.85% to $4.74 in premarket trading.

Portfolio Pulse from Shivani Kumaresan

March 27, 2024 | 11:35 am

ARM

LDTC

LeddarTech announced a strengthened collaboration with Arm, planning to showcase its LeddarVision technology, powered by Arm's Automotive Enhanced technology, at Embedded World in April 2024. This follows a previous announcement on March 13, 2024, about their partnership.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:35 am

VERB

VERB Technology Company, Inc. (VERB) has entered into a partnership with TikTok, becoming a service provider for TikTok Shop and officially designated as a TikTok Shop Partner. This collaboration marks a significant milestone for VERB, potentially expanding its market reach and enhancing its service offerings through the integration with one of the world's leading social media platforms.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:33 am

AMD

INTC

NVDA

SK Hynix expects its high-bandwidth memory (HBM) chips, used in AI chipsets, to make up a significant portion of its DRAM sales by 2024, benefiting Nvidia as a key recipient. SK Hynix, a leading supplier of HBM3 chips to Nvidia, anticipates these chips will represent 15% of global DRAM sales in 2024, up from 8% in 2023. The company also plans a $4 billion chip-packaging facility in Indiana, supported by the U.S. Chips Act. This development comes amid heightened U.S.-China semiconductor tensions, with China reducing its reliance on U.S. microprocessors from Intel and AMD.

Portfolio Pulse from Anusuya Lahiri

March 27, 2024 | 11:30 am

IBIO

IBio shares surged following the announcement of a collaboration with AstralBio to develop AI-powered antibodies for obesity and cardiometabolic diseases.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:23 am

LOCL

Local Bounti Corporation announced it has received a patent for its proprietary Stack & Flow technology, which could enhance its competitive edge in the agricultural tech sector.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:23 am

DIA

GLD

QQQ

SPY

USO

On March 26th, U.S. markets closed lower, with the Dow, S&P 500, and Nasdaq all experiencing losses. Economic data showed a rise in U.S. durable goods orders and home prices. Asian markets were mixed, with gains in Japan, Australia, and India, but losses in China and Hong Kong. European markets saw slight gains, except for the U.K.'s FTSE 100. Commodities saw crude oil and natural gas prices drop, while gold and silver prices increased. U.S. futures indicated a positive opening for the next trading session.

Portfolio Pulse from Akanksha Bakshi

March 27, 2024 | 11:22 am

MSFT

NABL

N-able, Inc. (NYSE:NABL) has launched N-able Cloud Commander, a multi-tenant solution for the Microsoft Cloud, designed to help managed services providers (MSPs) manage, secure, standardize, and automate Microsoft 365 users, Azure resources, and Intune devices from a single console. The company also plans to incorporate Windows 365 management capabilities into Cloud Commander.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:17 am

NVCR

Novocure's METIS Phase 3 trial met its primary endpoint, showing a significant extension in time to intracranial progression for brain metastases from non-small cell lung cancer, leading to a rise in its shares.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 11:17 am